Decreasing Post-Operative Nausea and Vomiting in the Bariatric Surgical Patient
1 other identifier
interventional
50
1 country
1
Brief Summary
From the research and current studies, post-operative nausea and vomiting is a common complaint after bariatric surgery. Nausea relief inhalers could improve post-operative nausea and vomiting without the need for further medications, subsequently reducing the chance of side effects. This study could help improve patient satisfaction and increase the ability of the patient to ambulate after surgery with the use of a nausea relief inhaler.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2020
CompletedStudy Start
First participant enrolled
December 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 27, 2023
CompletedFirst Posted
Study publicly available on registry
October 31, 2023
CompletedMay 1, 2026
April 1, 2026
2.5 years
November 18, 2020
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Medication Administration Record
The amount of nausea and vomiting medication use will be determined by the medication administration record during chart review in the first 24 hours for each study patient.
"Up to 24 hours"
Secondary Outcomes (2)
Rhodes index
"Up to 24 hours"
Length of stay
duration of hospital stay: date of discharge minus date of admittance)
Study Arms (1)
Aromatherapy
OTHERInterventions
Aromatherapy and essential oils are an alternative method to controlling post-operative nausea and vomiting after post-surgical intervention.
Eligibility Criteria
You may qualify if:
- Age 18 to 65 years old
- Attend the pre-operative class
- Must be able to read English
- Admitted to B4 surgical acute unit
- Surgery after May 31st, 2020
You may not qualify if:
- BMI greater than 60
- Pre-operatively on nausea medication
- Allergy to spearmint, lemon, ginger, and/or cedarwood
- History of Asthma or chronic obstructive pulmonary disease(COPD)
- Patient intubated or sedated for the 24 hours after surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist Mansfield Medical Center
Mansfield, Texas, 76063, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ashley Attaway, RN
Methodist Mansfield Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2020
First Posted
October 31, 2023
Study Start
December 23, 2020
Primary Completion
June 20, 2023
Study Completion
June 27, 2023
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share